Peking University Resources (Holdings) Company Limited (00618.HK) announced that ResoHealth, the Group’s Dubai-based healthcare business unit, has partnered with Trivitron Healthcare to launch the Trivitron Digital AI Digital Health Initiative in India. The platform aims to enhance the operational efficiency of hospitals and the patient diagnosis and treatment experience in India’s tier-2 and tier-3 cities through cloud solutions and AI technologies, with future plans to expand into the African, Middle Eastern and Southeast Asian markets.
MIRXES-B (02629.HK) announced that it has established a strategic cooperation with N Health, an affiliate of BDMS (Bangkok Dusit Medical Services (BDMS) Group)—Thailand’s largest healthcare provider—to jointly promote miRNA cancer screening solutions in Thailand. In addition, two of the Company’s at-home test kits (Helicobacter pylori and fecal occult blood tests) have obtained approval from Thailand’s FDA and are officially launched on January 9, 2026.
HKBN announced that it has restored the 25% minimum public float as required by the Listing Rules of the Hong Kong Stock Exchange. As of the announcement date, the public holds 370,812,000 shares of the company, accounting for 25.07% of the total issued shares. China Mobile Hong Kong and its concert parties maintain their shareholding ratio at 74.84% unchanged, while the shareholding ratio of core connected persons (excluding China Mobile Hong Kong) has decreased from 2.25% to 0.09%.
Sino Harbour Holdings Group Chairman Wang Linbing increased his stake through open market purchases on December 15, 2025 and January 8, 2026, acquiring 11.95 million shares at an average price of HK$0.061 per share, further raising his shareholding percentage as a major shareholder.
WINOX announced that for the 11 months ended November 30, 2025, the group recorded an unaudited loss of approximately HK$54 million, a significant expansion compared to the full-year loss of HK$20.329 million in 2024. The loss is mainly attributed to declining revenue due to weak market demand, falling overall gross profit margin amid intensified market competition, and severance compensation arising from the group's workforce streamlining plan.
ALLAN INT'L announced on January 8 that its public float is approximately 24.04%, still below the 25% minimum requirement set by the Hong Kong Listing Rules. The announcement also disclosed the shareholding structure, with core related parties collectively holding over 75% of the shares. Currently, the company is in discussions with core related parties to reduce their respective shareholdings in order to restore the public float to a compliant level, and the relevant discussions are still ongoing.
MINIEYE(02431.HK) will spend HKD 25.8 million to repurchase 1.75 million shares on Jan 7, 2026 .
XIAOMI-W(01810.HK) will spend HKD 148.84 million to repurchase 3.9 million shares on Jan 7, 2026 .
China International Capital Corporation Limited (03908.HK) announced that the first tranche of its 2026 publicly issued perpetual subordinated bonds targeting professional investors will be book-built on January 8, 2026. The issuance size shall not exceed RMB 3 billion, the bond is abbreviated as "26 CICC Y1", and the coupon rate inquiry range is set at 1.90%-2.90%.
Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. (02582.HK) announced that it has entered into a pre-purchase order agreement with its 14%-owned Australian associate company, LineHydrogen (Australia) Pty Ltd, for the Tasmania Hydrogen Energy Project in Australia. The agreement covers a variety of equipment and services such as electrolytic hydrogen production systems and hydrogen refueling stations.
Eurasia Aerosol, a subsidiary of Precious PRECIOUS DRAGON, has entered into a construction agreement with a contractor to carry out the construction and renovation project of its production factory in Guangzhou, with a total investment of RMB34.8 million (approximately HK$38.3 million). Expected to be completed by July 29, 2026, the project will help the company expand production capacity, meet the requirements of environmental regulations, and enhance the competitiveness of its Original Brand Manufacturing (OBM) business.
SHANXI INSTALL announced that its proposed issuance of domestic corporate bonds has obtained the registration approval from the China Securities Regulatory Commission (CSRC). The approval permits the company to publicly issue corporate bonds with a total par value not exceeding RMB1.35 billion to professional investors, with a validity period of 24 months for the approval, during which the company may issue the bonds in installments.
QHD PORT announced that its total throughput in 2025 reached 432.53 million tons, a year-on-year (YoY) increase of 4.48% compared with 414.00 million tons in 2024. The throughput of the company's three major ports all achieved YoY growth, among which Huanghua Port led with a growth rate of 8.04%, while Qinhuangdao Port and Caofeidian Port recorded growth rates of 3.81% and 2.74% respectively.
HUTCHMED announced that the Phase III stage of the ESLIM-02 study on its Syk inhibitor sostarlimab for the treatment of warm antibody autoimmune hemolytic anemia has met the primary endpoint, namely sustained hemoglobin response during the treatment period from Week 5 to Week 24. The study targets patients who relapsed or were refractory after previous standard treatments. The company plans to submit a new drug application for this indication to the National Medical Products Administration in the first half of 2026. The Phase III study of sostarlimab for the treatment of immune thrombocytopenia has also achieved positive results, and the company similarly plans to resubmit a new drug application for this indication in the first half of 2026.
J&T Express (1519) announced its operating data for the fourth quarter and the full year of 2025. The annual package volume reached 30.129 billion, an increase of 22.2% year-on-year. Among them, the Southeast Asian market grew by 67.8% to 7.659 billion, and the new market grew by 43.6% to 404 million. The total package volume in the fourth quarter was 8.461 billion, an increase of 14.5% year-on-year. As of the end of 2025, the number of outlets in Southeast Asia increased to 10,800, and the number of trunk vehicles increased to 5,800. The company plans to hold a conference call on January 7, 2026, and the relevant data is unaudited.
Leadrive Technology recently filed a prospectus with the Hong Kong Stock Exchange for a Main Board listing, with CITIC Securities and Haitong International as joint sponsors. According to Frost & Sullivan, by installed capacity in the first three quarters of 2025, the company's motor controllers ranked eighth, dual-motor controllers ranked third; main drive power bricks ranked second, and power bricks for dual-motor controllers ranked first.
